Merck Tbk PT
IDX:MERK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Merck Tbk PT
EPS (Diluted)
Merck Tbk PT
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Merck Tbk PT
IDX:MERK
|
EPS (Diluted)
Rp544
|
CAGR 3-Years
11%
|
CAGR 5-Years
28%
|
CAGR 10-Years
6%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
EPS (Diluted)
Rp312
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
EPS (Diluted)
Rp80
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
EPS (Diluted)
Rp47
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
EPS (Diluted)
-Rp33
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
EPS (Diluted)
-Rp60
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck Tbk PT
Glance View
PT Merck Tbk engages in the pharmaceutical and chemical businesses. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 384 full-time employees. The firm is also engaged in the business of leasing and property management. The Company’s segments include Cardiovascular, Metabolic, Oncology, Endocrinology, Fertility, Neurodegenerative and General Medicines. The Cardiovascular segment provides a range of products, including Amcor, Concor and Lodoz. The Metabolic segment provides a range of products, including Glucophage, Glucophage XR, Glucovance Euthyrox and Thyrozol. The Oncology provides Erbitux product. The Endocrinology provides Saizen product. The Fertility segments include Gonal-F, Pergoveris, Cetrotide, Crinone and Ovidrel products. The Neurodegenerative provides Rebif product. The General Medicines segment provides Encephabol, KSR, Biocream, Praxilene and Stilamin products.
See Also
What is Merck Tbk PT's EPS (Diluted)?
EPS (Diluted)
544.4
IDR
Based on the financial report for Dec 31, 2025, Merck Tbk PT's EPS (Diluted) amounts to 544.4 IDR.
What is Merck Tbk PT's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
6%
Over the last year, the EPS (Diluted) growth was 59%. The average annual EPS (Diluted) growth rates for Merck Tbk PT have been 11% over the past three years , 28% over the past five years , and 6% over the past ten years .
